Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
Viscosupplementation Market Growth & Trends
The global viscosupplementation market size is expected to reach USD 7.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.37% from 2021 to 2028. Initiatives to increase awareness regarding available treatment, the rising geriatric population, and product advancements are expected to boost market growth during the forecast period. With the growing geriatric population, the burden of osteoarthritis is expected to increase dramatically. As per the Arthritis Foundation, in the U.S., around 54.4 million adults are reported to be diagnosed with doctor-diagnosed arthritis.
Favorable reimbursement policies with respect to the geriatric population are expected to act as an opportunity for market growth. The viscosupplementation business was affected due to the COVID-19 pandemic as many healthcare providers postponed the nonessential patient visits, such as osteoarthritis treatments. Although ease in COVID-19 restrictions regarding surgeries led to a recovery in surgery volume, certain markets, such as Spain, the U.K., and Italy witnessed a low pace of recovery. Asia Pacific held the largest revenue share of the global market in 2020.
In recent years, exponential growth in the number of orthopedic surgeons in developing countries, such as South Korea, Russia, and China, was observed. Asia Pacific region presents high growth potential owing to large patient population and untapped opportunities in comparison with the U.S. Therefore, the introduction of products by the players in Asian countries is further expected to propel the market growth. In July 2017, Anika Therapeutics announced regulatory approval of MONOVISC in India followed by approval in Australia in October 2017.
However, such strategic initiatives were offset to some extent by the impact of the COVID-19 pandemic, which led to the disruption of company operations. Europe is expected to register the fastest CAGR during the forecast period. This can be attributed to a large number of clinical trials being conducted in the region to provide efficient treatment for knee osteoarthritis with the help of stem cells.
Viscosupplementation Market Report Highlights
Viscosupplementation Market Growth & Trends
The global viscosupplementation market size is expected to reach USD 7.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.37% from 2021 to 2028. Initiatives to increase awareness regarding available treatment, the rising geriatric population, and product advancements are expected to boost market growth during the forecast period. With the growing geriatric population, the burden of osteoarthritis is expected to increase dramatically. As per the Arthritis Foundation, in the U.S., around 54.4 million adults are reported to be diagnosed with doctor-diagnosed arthritis.
Favorable reimbursement policies with respect to the geriatric population are expected to act as an opportunity for market growth. The viscosupplementation business was affected due to the COVID-19 pandemic as many healthcare providers postponed the nonessential patient visits, such as osteoarthritis treatments. Although ease in COVID-19 restrictions regarding surgeries led to a recovery in surgery volume, certain markets, such as Spain, the U.K., and Italy witnessed a low pace of recovery. Asia Pacific held the largest revenue share of the global market in 2020.
In recent years, exponential growth in the number of orthopedic surgeons in developing countries, such as South Korea, Russia, and China, was observed. Asia Pacific region presents high growth potential owing to large patient population and untapped opportunities in comparison with the U.S. Therefore, the introduction of products by the players in Asian countries is further expected to propel the market growth. In July 2017, Anika Therapeutics announced regulatory approval of MONOVISC in India followed by approval in Australia in October 2017.
However, such strategic initiatives were offset to some extent by the impact of the COVID-19 pandemic, which led to the disruption of company operations. Europe is expected to register the fastest CAGR during the forecast period. This can be attributed to a large number of clinical trials being conducted in the region to provide efficient treatment for knee osteoarthritis with the help of stem cells.
Viscosupplementation Market Report Highlights
- Single-injection led the type segment in 2020 and is expected to register the fastest growth rate over the forecast period due to various factors, such as new product launch and affordability as compared to their counterparts
- For instance, in March 2019, SeikagakuCorp. launched an intra-articular single injection viscosupplement “HyLink” for the therapy of knee osteoarthritis in Italy
- The orthopedic clinics/ASC send-use segment is expected to exhibit the fastest CAGR during the forecast period. The increasing prevalence of osteoarthritis among the geriatric population is one of the major factors expected to contribute to the segment growth
- Collaborations for development & expansion of product portfolios and geographical expansion in emerging markets are key strategies adopted by companies to increase their market share
- For instance, in June 2020, Seikagaku Corporation completed acquiring all shares of Dalton Chemical Laboratories, Inc., an unlisted company in Canada
CHAPTER 1 REPORT SCOPE AND OBJECTIVES
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective -
1.4.2 Objective -
1.4.3 Objective -
CHAPTER 2 METHODOLOGY
2.1 Research Methodology
2.1.1 Information procurement
2.1.2 Purchased Database
2.1.3 GVR’s Internal Database
2.1.4 Secondary Sources
2.1.5 Primary Research
2.2 Information or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis
2.5 List of Secondary Sources
2.6 List of Abbreviations
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product
3.2.2 End use
3.3 Regional Outlook
3.4 Competitive Insights
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Related/Ancillary Market Outlook
4.2 Viscosupplementation Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Increasing prevalence of osteoarthritis among geriatric population
4.2.1.2 New product development
4.2.2 Market Restraint Analysis
4.2.2.1 High cost of products
4.2.2.2 Side effects associated with hyaluronic acid cycles
4.3 Viscosupplementation Market: Business Environment Analysis Tools
4.3.1 PESTLE Analysis
4.3.1.1 Political & legal
4.3.1.2 Economic & social
4.3.1.3 Technological
4.3.2 Porter’s five forces analysis
4.3.2.1 Threat of new entrants: Low
4.3.2.2 Bargaining power of buyers: Moderate
4.3.2.3 Competitive rivalry: High
4.3.2.4 Threat of substitutes: Moderate
4.3.2.5 Bargaining power of suppliers: High
4.4 Penetration & Growth Prospect Mapping
4.5 Clinical Trials
4.6 Major Deals & Strategic Alliances Analysis
4.6.1 Mergers & Acquisitions
4.6.2 Licensing & partnerships, technology collaborations
4.7 Product Pricing Analysis
4.7.1 North America
4.7.2 Europe
4.7.3 Asia Pacific
4.7.4 Latin America
4.7.5 Middle east & Africa
4.8 Distribution Channel Analysis
4.8.1 Distribution and marketing rights of Viscosupplements
4.8.2 North America
4.8.3 Europe
4.8.4 Asia Pacific
4.8.5 Latin America
4.8.6 Middle East & Africa
4.9 Impact of COVID-19 on Viscosupplementation Market
CHAPTER 5 VISCOSUPPLEMENTATION MARKET: PRODUCT ANALYSIS
5.1 Viscosupplementation Market: Product Movement Analysis, 2020 & 2028
5.2 Viscosupplementation Product Market: Segment Dashboard
5.2.1 Single Injection
5.2.1.1 Single injection market, 2016-2028 (USD Million)
5.2.2 Three Injection
5.2.2.1 Three injection market, 2016-2028 (USD Million)
5.2.3 Five Injection
5.2.3.1 Five injection market, 2016-2028 (USD Million)
5.2.4 Product Information
5.2.4.1 Durolane
5.2.4.2 GelSyn-3
5.2.4.3 GenVisc
5.2.4.4 Hymovis
5.2.4.5 Supartz FX
5.2.4.6 TriVisc
5.2.4.7 Visco-3
5.2.4.8 Ostenil
5.2.4.9 Adant
CHAPTER 6 VISCOSUPPLEMENTATION MARKET: END-USE ANALYSIS
6.1 Viscosupplementation Market: End Use Movement Analysis, 2020 & 2028
6.2 Viscosupplementation End Use Market: Segment Dashboard
6.2.1 Hospitals
6.2.1.1 Hospitals market, 2016-2028 (USD Million)
6.2.2 Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
6.2.2.1 Orthopedic clinics/ambulatory surgical centers (ASCs) market, 2016-2028 (USD Million)
CHAPTER 7 VISCOSUPPLEMENTATION MARKET: REGIONAL ANALYSIS
7.1 Regional Movement Analysis & Market Share, 2020 & 2028
7.2 SWOT Analysis, by Factor
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East and Africa
7.3 North America
7.3.1 North America viscosupplementation Market, 2016 - 2028 (USD Million)
7.3.2 The U.S.
7.3.2.1 Regulatory and reimbursement scenario
7.3.2.2 The U.S. viscosupplementation market, 2016 - 2028 (USD Million)
7.3.3 Canada
7.3.3.1 Regulatory and reimbursement scenario
7.3.3.2 Canada viscosupplementation market, 2016 - 2028 (USD Million)
7.4 Europe
7.4.1 Europe viscosupplementation market, 2016 - 2028 (USD Million)
7.4.2 The U.K.
7.4.2.1 Regulatory and reimbursement scenario
7.4.2.2 The U.K. viscosupplementation market, 2016 - 2028 (USD Million)
7.4.3 Germany
7.4.3.1 Regulatory and reimbursement scenario
7.4.3.2 Germany viscosupplementation market, 2016 - 2028 (USD Million)
7.4.4 France
7.4.4.1 Regulatory and reimbursement scenario
7.4.4.2 France viscosupplementation market, 2016 - 2028 (USD Million)
7.4.5 Italy
7.4.5.1 Regulatory and reimbursement scenario
7.4.5.2 Italy viscosupplementation market, 2016 - 2028 (USD Million)
7.4.6 Spain
7.4.6.1 Regulatory and reimbursement scenario
7.4.6.2 Spain viscosupplementation market, 2016 - 2028 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific viscosupplementation market, 2016 - 2028 (USD Million)
7.5.2 China
7.5.2.1 Regulatory and reimbursement scenario
7.5.2.2 China viscosupplementation market, 2016 - 2028 (USD Million)
7.5.3 Japan
7.5.3.1 Regulatory and reimbursement scenario
7.5.3.2 Japan viscosupplementation market, 2016 - 2028 (USD Million)
7.5.4 India
7.5.4.1 Regulatory and reimbursement scenario
7.5.4.2 India viscosupplementation market, 2016 - 2028 (USD Million)
7.5.5 South Korea
7.5.5.1 Regulatory and reimbursement scenario
7.5.5.2 South Korea viscosupplementation market, 2016 - 2028 (USD Million)
7.5.6 Australia
7.5.6.1 Regulatory and reimbursement scenario
7.5.6.2 Australia viscosupplementation market, 2016 - 2028 (USD Million)
7.6 Latin America
7.6.1 Regulatory and reimbursement scenario
7.6.2 Latin America viscosupplementation market, 2016 - 2028 (USD Million)
7.6.3 Brazil
7.6.3.1 Regulatory and reimbursement scenario
7.6.3.2 Brazil viscosupplementation market, 2016 - 2028 (USD Million)
7.6.4 Mexico
7.6.4.1 Regulatory and reimbursement scenario
7.6.4.2 Mexico viscosupplementation market, 2016 - 2028 (USD Million)
7.6.5 Argentina
7.6.5.1 Regulatory and reimbursement scenario
7.6.5.2 Argentina viscosupplementation market, 2016 - 2028 (USD Million)
7.6.6 Colombia
7.6.6.1 Colombia viscosupplementation market, 2016 - 2028 (USD Million)
7.7 Middle East & Africa
7.7.1 Middle East & Africa viscosupplementation market, 2016 - 2028 (USD Million)
7.7.2 South Africa
7.7.2.1 Regulatory and reimbursement scenario
7.7.2.2 South Africa viscosupplementation market, 2016 - 2028 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Regulatory and reimbursement scenario
7.7.3.2 Saudi Arabia viscosupplementation market, 2016 - 2028 (USD Million)
7.7.4 UAE
7.7.4.1 UAE viscosupplementation market, 2016 - 2028 (USD Million)
CHAPTER 8 REIMBURSEMENT OUTLOOK
8.1 Direct Medical Cost of Treatment of Osteoarthritis (Percentage Distribution)
8.2 Reimbursement by Product
8.2.1 Gel - one
8.2.2 Euflexxa
8.2.3 Synvisc - one
8.2.4 Supartz
8.2.5 Hyalgan
8.2.6 Monovisc
8.2.7 Orthovisc
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Recent Development & Impact Analysis by Key Market Participants
9.2 Competition Categorization
9.3 Company Market Position Analysis
9.4 Company Profiles
9.4.1 Sanofi
9.4.1.1 Company overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.1.5 SWOT analysis
9.4.2 Anika Therapeutics, Inc.
9.4.2.1 Company overview
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.2.5 SWOT analysis
9.4.3 SEIKAGAKU CORPORATION
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.3.5 SWOT analysis
9.4.4 Zimmer Biomet
9.4.4.1 Company overview
9.4.4.2 Financial performance
9.4.4.3 Product benchmarking
9.4.4.4 Strategic initiatives
9.4.4.5 SWOT analysis
9.4.5 Smith & Nephew PLC
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.5.5 SWOT analysis
9.4.6 Ferring Pharmaceutical B.V.
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 Lifecore Biomedical, LLC (Landec)
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.7.5 SWOT analysis
9.4.8 LG Life Sciences Ltd.
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.8.5 SWOT analysis
9.4.9 Fidia Farmaceutici S.p.A
9.4.9.1 Company overview
9.4.9.2 Financial performance
9.4.9.3 Product benchmarking
9.4.9.4 Strategic initiatives
9.4.10 F.Hoffmann-La Roche Ltd.
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives
9.4.10.5 SWOT analysis
CHAPTER 10 RECOMMENDATIONS
1.1 Market Segmentation
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Research Objectives
1.4.1 Objective -
1.4.2 Objective -
1.4.3 Objective -
CHAPTER 2 METHODOLOGY
2.1 Research Methodology
2.1.1 Information procurement
2.1.2 Purchased Database
2.1.3 GVR’s Internal Database
2.1.4 Secondary Sources
2.1.5 Primary Research
2.2 Information or Data Analysis
2.2.1 Data Analysis Models
2.3 Market Formulation & Validation
2.4 Model Details
2.4.1 Commodity Flow Analysis
2.5 List of Secondary Sources
2.6 List of Abbreviations
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Outlook
3.2 Segment Outlook
3.2.1 Product
3.2.2 End use
3.3 Regional Outlook
3.4 Competitive Insights
CHAPTER 4 MARKET VARIABLES, TRENDS & SCOPE
4.1 Market Lineage Outlook
4.1.1 Parent Market Outlook
4.1.2 Related/Ancillary Market Outlook
4.2 Viscosupplementation Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Increasing prevalence of osteoarthritis among geriatric population
4.2.1.2 New product development
4.2.2 Market Restraint Analysis
4.2.2.1 High cost of products
4.2.2.2 Side effects associated with hyaluronic acid cycles
4.3 Viscosupplementation Market: Business Environment Analysis Tools
4.3.1 PESTLE Analysis
4.3.1.1 Political & legal
4.3.1.2 Economic & social
4.3.1.3 Technological
4.3.2 Porter’s five forces analysis
4.3.2.1 Threat of new entrants: Low
4.3.2.2 Bargaining power of buyers: Moderate
4.3.2.3 Competitive rivalry: High
4.3.2.4 Threat of substitutes: Moderate
4.3.2.5 Bargaining power of suppliers: High
4.4 Penetration & Growth Prospect Mapping
4.5 Clinical Trials
4.6 Major Deals & Strategic Alliances Analysis
4.6.1 Mergers & Acquisitions
4.6.2 Licensing & partnerships, technology collaborations
4.7 Product Pricing Analysis
4.7.1 North America
4.7.2 Europe
4.7.3 Asia Pacific
4.7.4 Latin America
4.7.5 Middle east & Africa
4.8 Distribution Channel Analysis
4.8.1 Distribution and marketing rights of Viscosupplements
4.8.2 North America
4.8.3 Europe
4.8.4 Asia Pacific
4.8.5 Latin America
4.8.6 Middle East & Africa
4.9 Impact of COVID-19 on Viscosupplementation Market
CHAPTER 5 VISCOSUPPLEMENTATION MARKET: PRODUCT ANALYSIS
5.1 Viscosupplementation Market: Product Movement Analysis, 2020 & 2028
5.2 Viscosupplementation Product Market: Segment Dashboard
5.2.1 Single Injection
5.2.1.1 Single injection market, 2016-2028 (USD Million)
5.2.2 Three Injection
5.2.2.1 Three injection market, 2016-2028 (USD Million)
5.2.3 Five Injection
5.2.3.1 Five injection market, 2016-2028 (USD Million)
5.2.4 Product Information
5.2.4.1 Durolane
5.2.4.2 GelSyn-3
5.2.4.3 GenVisc
5.2.4.4 Hymovis
5.2.4.5 Supartz FX
5.2.4.6 TriVisc
5.2.4.7 Visco-3
5.2.4.8 Ostenil
5.2.4.9 Adant
CHAPTER 6 VISCOSUPPLEMENTATION MARKET: END-USE ANALYSIS
6.1 Viscosupplementation Market: End Use Movement Analysis, 2020 & 2028
6.2 Viscosupplementation End Use Market: Segment Dashboard
6.2.1 Hospitals
6.2.1.1 Hospitals market, 2016-2028 (USD Million)
6.2.2 Orthopedic Clinics/Ambulatory Surgical Centers (ASCS)
6.2.2.1 Orthopedic clinics/ambulatory surgical centers (ASCs) market, 2016-2028 (USD Million)
CHAPTER 7 VISCOSUPPLEMENTATION MARKET: REGIONAL ANALYSIS
7.1 Regional Movement Analysis & Market Share, 2020 & 2028
7.2 SWOT Analysis, by Factor
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East and Africa
7.3 North America
7.3.1 North America viscosupplementation Market, 2016 - 2028 (USD Million)
7.3.2 The U.S.
7.3.2.1 Regulatory and reimbursement scenario
7.3.2.2 The U.S. viscosupplementation market, 2016 - 2028 (USD Million)
7.3.3 Canada
7.3.3.1 Regulatory and reimbursement scenario
7.3.3.2 Canada viscosupplementation market, 2016 - 2028 (USD Million)
7.4 Europe
7.4.1 Europe viscosupplementation market, 2016 - 2028 (USD Million)
7.4.2 The U.K.
7.4.2.1 Regulatory and reimbursement scenario
7.4.2.2 The U.K. viscosupplementation market, 2016 - 2028 (USD Million)
7.4.3 Germany
7.4.3.1 Regulatory and reimbursement scenario
7.4.3.2 Germany viscosupplementation market, 2016 - 2028 (USD Million)
7.4.4 France
7.4.4.1 Regulatory and reimbursement scenario
7.4.4.2 France viscosupplementation market, 2016 - 2028 (USD Million)
7.4.5 Italy
7.4.5.1 Regulatory and reimbursement scenario
7.4.5.2 Italy viscosupplementation market, 2016 - 2028 (USD Million)
7.4.6 Spain
7.4.6.1 Regulatory and reimbursement scenario
7.4.6.2 Spain viscosupplementation market, 2016 - 2028 (USD Million)
7.5 Asia Pacific
7.5.1 Asia Pacific viscosupplementation market, 2016 - 2028 (USD Million)
7.5.2 China
7.5.2.1 Regulatory and reimbursement scenario
7.5.2.2 China viscosupplementation market, 2016 - 2028 (USD Million)
7.5.3 Japan
7.5.3.1 Regulatory and reimbursement scenario
7.5.3.2 Japan viscosupplementation market, 2016 - 2028 (USD Million)
7.5.4 India
7.5.4.1 Regulatory and reimbursement scenario
7.5.4.2 India viscosupplementation market, 2016 - 2028 (USD Million)
7.5.5 South Korea
7.5.5.1 Regulatory and reimbursement scenario
7.5.5.2 South Korea viscosupplementation market, 2016 - 2028 (USD Million)
7.5.6 Australia
7.5.6.1 Regulatory and reimbursement scenario
7.5.6.2 Australia viscosupplementation market, 2016 - 2028 (USD Million)
7.6 Latin America
7.6.1 Regulatory and reimbursement scenario
7.6.2 Latin America viscosupplementation market, 2016 - 2028 (USD Million)
7.6.3 Brazil
7.6.3.1 Regulatory and reimbursement scenario
7.6.3.2 Brazil viscosupplementation market, 2016 - 2028 (USD Million)
7.6.4 Mexico
7.6.4.1 Regulatory and reimbursement scenario
7.6.4.2 Mexico viscosupplementation market, 2016 - 2028 (USD Million)
7.6.5 Argentina
7.6.5.1 Regulatory and reimbursement scenario
7.6.5.2 Argentina viscosupplementation market, 2016 - 2028 (USD Million)
7.6.6 Colombia
7.6.6.1 Colombia viscosupplementation market, 2016 - 2028 (USD Million)
7.7 Middle East & Africa
7.7.1 Middle East & Africa viscosupplementation market, 2016 - 2028 (USD Million)
7.7.2 South Africa
7.7.2.1 Regulatory and reimbursement scenario
7.7.2.2 South Africa viscosupplementation market, 2016 - 2028 (USD Million)
7.7.3 Saudi Arabia
7.7.3.1 Regulatory and reimbursement scenario
7.7.3.2 Saudi Arabia viscosupplementation market, 2016 - 2028 (USD Million)
7.7.4 UAE
7.7.4.1 UAE viscosupplementation market, 2016 - 2028 (USD Million)
CHAPTER 8 REIMBURSEMENT OUTLOOK
8.1 Direct Medical Cost of Treatment of Osteoarthritis (Percentage Distribution)
8.2 Reimbursement by Product
8.2.1 Gel - one
8.2.2 Euflexxa
8.2.3 Synvisc - one
8.2.4 Supartz
8.2.5 Hyalgan
8.2.6 Monovisc
8.2.7 Orthovisc
CHAPTER 9 COMPETITIVE LANDSCAPE
9.1 Recent Development & Impact Analysis by Key Market Participants
9.2 Competition Categorization
9.3 Company Market Position Analysis
9.4 Company Profiles
9.4.1 Sanofi
9.4.1.1 Company overview
9.4.1.2 Financial performance
9.4.1.3 Product benchmarking
9.4.1.4 Strategic initiatives
9.4.1.5 SWOT analysis
9.4.2 Anika Therapeutics, Inc.
9.4.2.1 Company overview
9.4.2.2 Financial performance
9.4.2.3 Product benchmarking
9.4.2.4 Strategic initiatives
9.4.2.5 SWOT analysis
9.4.3 SEIKAGAKU CORPORATION
9.4.3.1 Company overview
9.4.3.2 Financial performance
9.4.3.3 Product benchmarking
9.4.3.4 Strategic initiatives
9.4.3.5 SWOT analysis
9.4.4 Zimmer Biomet
9.4.4.1 Company overview
9.4.4.2 Financial performance
9.4.4.3 Product benchmarking
9.4.4.4 Strategic initiatives
9.4.4.5 SWOT analysis
9.4.5 Smith & Nephew PLC
9.4.5.1 Company overview
9.4.5.2 Financial performance
9.4.5.3 Product benchmarking
9.4.5.4 Strategic initiatives
9.4.5.5 SWOT analysis
9.4.6 Ferring Pharmaceutical B.V.
9.4.6.1 Company overview
9.4.6.2 Financial performance
9.4.6.3 Product benchmarking
9.4.6.4 Strategic initiatives
9.4.7 Lifecore Biomedical, LLC (Landec)
9.4.7.1 Company overview
9.4.7.2 Financial performance
9.4.7.3 Product benchmarking
9.4.7.4 Strategic initiatives
9.4.7.5 SWOT analysis
9.4.8 LG Life Sciences Ltd.
9.4.8.1 Company overview
9.4.8.2 Financial performance
9.4.8.3 Product benchmarking
9.4.8.4 Strategic initiatives
9.4.8.5 SWOT analysis
9.4.9 Fidia Farmaceutici S.p.A
9.4.9.1 Company overview
9.4.9.2 Financial performance
9.4.9.3 Product benchmarking
9.4.9.4 Strategic initiatives
9.4.10 F.Hoffmann-La Roche Ltd.
9.4.10.1 Company overview
9.4.10.2 Financial performance
9.4.10.3 Product benchmarking
9.4.10.4 Strategic initiatives
9.4.10.5 SWOT analysis
CHAPTER 10 RECOMMENDATIONS
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Cost of viscosupplements - U.S.
TABLE 4 HCPCS codes
TABLE 5 Labelling instructions by the FDA
TABLE 6 Distribution and marketing rights of Synvisc
TABLE 7 Global single injection market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 8 Global three injection market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 9 Global five injection market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 10 Global hospitals market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 11 Global orthopedic clinics/Ambulatory Surgical Centers (ASCs) market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 12 North America viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 13 North America viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 14 North America viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 15 The U.S. viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 16 The U.S. viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 17 The U.S. viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 18 Canada viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 19 Canada viscosupplementation market revenue estimates and forecast by type, 2016 - 2028 (USD Million)
TABLE 20 Canada viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 21 Europe viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 22 Europe viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 23 Europe viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 24 The U.K. viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 25 The U.K. viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 26 The U.K. viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 27 Germany viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 28 Germany viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 29 Germany viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 30 France viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 31 France viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 32 France viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 33 Italy viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 34 Italy viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 35 Italy viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 36 Spain viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 37 Spain viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 38 Spain viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 39 Asia Pacific viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 40 Asia Pacific viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 41 Asia Pacific viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 42 China viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 43 China viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 44 China viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 45 Japan viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 46 Japan viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 47 Japan viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 48 India viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 49 India viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 50 India viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 51 South Korea viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 52 South Korea viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 53 South Korea viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 54 Australia viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 55 Australia viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 56 Australia viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 57 Latin America viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 58 Latin America viscosupplementation market revenue estimates and forecast by type, 2016 - 2028 (USD Million)
TABLE 59 Latin America viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 60 Brazil viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 61 Brazil viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 62 Brazil viscosupplementation market revenue estimates and forecast by t, 2016 - 2028 (USD Million)
TABLE 63 Mexico viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 64 Mexico viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 65 Mexico viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 66 Argentina viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 67 Argentina viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 68 Argentina viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 69 Colombia viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 70 Colombia viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 71 Colombia viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 72 Middle East & Africa (MEA) viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 73 Middle East & Africa (MEA) viscosupplementation market revenue estimates and forecast by type, 2016 - 2028 (USD Million)
TABLE 74 Middle East & Africa (MEA) viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 75 South Africa viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 76 South Africa viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 77 South Africa viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 78 Saudi Arabia viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 79 Saudi Arabia viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 80 Saudi Arabia viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 81 UAE viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 82 UAE viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 83 UAE viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Cost of viscosupplements - U.S.
TABLE 4 HCPCS codes
TABLE 5 Labelling instructions by the FDA
TABLE 6 Distribution and marketing rights of Synvisc
TABLE 7 Global single injection market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 8 Global three injection market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 9 Global five injection market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 10 Global hospitals market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 11 Global orthopedic clinics/Ambulatory Surgical Centers (ASCs) market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 12 North America viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 13 North America viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 14 North America viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 15 The U.S. viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 16 The U.S. viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 17 The U.S. viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 18 Canada viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 19 Canada viscosupplementation market revenue estimates and forecast by type, 2016 - 2028 (USD Million)
TABLE 20 Canada viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 21 Europe viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 22 Europe viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 23 Europe viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 24 The U.K. viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 25 The U.K. viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 26 The U.K. viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 27 Germany viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 28 Germany viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 29 Germany viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 30 France viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 31 France viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 32 France viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 33 Italy viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 34 Italy viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 35 Italy viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 36 Spain viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 37 Spain viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 38 Spain viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 39 Asia Pacific viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 40 Asia Pacific viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 41 Asia Pacific viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 42 China viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 43 China viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 44 China viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 45 Japan viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 46 Japan viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 47 Japan viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 48 India viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 49 India viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 50 India viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 51 South Korea viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 52 South Korea viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 53 South Korea viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 54 Australia viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 55 Australia viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 56 Australia viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 57 Latin America viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 58 Latin America viscosupplementation market revenue estimates and forecast by type, 2016 - 2028 (USD Million)
TABLE 59 Latin America viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 60 Brazil viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 61 Brazil viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 62 Brazil viscosupplementation market revenue estimates and forecast by t, 2016 - 2028 (USD Million)
TABLE 63 Mexico viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 64 Mexico viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 65 Mexico viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 66 Argentina viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 67 Argentina viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 68 Argentina viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 69 Colombia viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 70 Colombia viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 71 Colombia viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 72 Middle East & Africa (MEA) viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 73 Middle East & Africa (MEA) viscosupplementation market revenue estimates and forecast by type, 2016 - 2028 (USD Million)
TABLE 74 Middle East & Africa (MEA) viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 75 South Africa viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 76 South Africa viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 77 South Africa viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 78 Saudi Arabia viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 79 Saudi Arabia viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 80 Saudi Arabia viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
TABLE 81 UAE viscosupplementation market estimates and forecast, 2016 - 2028 (USD Million)
TABLE 82 UAE viscosupplementation market revenue estimates and forecast by product, 2016 - 2028 (USD Million)
TABLE 83 UAE viscosupplementation market revenue estimates and forecast by end-use, 2016 - 2028 (USD Million)
LIST OF FIGURES
FIG. 1 Viscosupplementation market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2020 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Viscosupplementation market: Product movement analysis (USD Millions)
FIG. 15 Viscosupplementation market product outlook: Segment dashboard
FIG. 16 Single injection market 2016 - 2028 (USD Million)
FIG. 17 Three injection market 2016 - 2028 (USD Million)
FIG. 18 Five injection market 2016 - 2028 (USD Million)
FIG. 19 Viscosupplementation market: End-use movement analysis (USD Million)
FIG. 20 Viscosupplementation market end-use outlook: Segment dashboard
FIG. 21 Hospitals market 2016 - 2028 (USD Million)
FIG. 22 Orthopedic clinics/ambulatory surgical centers (ASCs) market 2016 - 2028 (USD Million)
FIG. 23 Regional marketplace: Key takeaways
FIG. 24 Regional movement analysis, (USD Million)
FIG. 25 North America viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 26 The U.S. viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 27 Canada viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 28 Europe viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 29 The U.K. viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 30 Germany viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 31 France viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 32 Italy viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 33 Spain viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 34 Asia Pacific viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 35 China viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 36 Japan viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 37 India viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 38 South Korea viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 39 Australia viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 40 Latin America viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 41 Brazil viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 42 Mexico viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 43 Argentina viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 44 Colombia viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 45 Middle East & Africa viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 46 South Africa viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 47 Saudi Arabia viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 48 UAE viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 49 Recent development & impact analysis by key market participants
FIG. 50 Competition categorization
FIG. 51 Company market position analysis
FIG. 1 Viscosupplementation market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2020 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Viscosupplementation market: Product movement analysis (USD Millions)
FIG. 15 Viscosupplementation market product outlook: Segment dashboard
FIG. 16 Single injection market 2016 - 2028 (USD Million)
FIG. 17 Three injection market 2016 - 2028 (USD Million)
FIG. 18 Five injection market 2016 - 2028 (USD Million)
FIG. 19 Viscosupplementation market: End-use movement analysis (USD Million)
FIG. 20 Viscosupplementation market end-use outlook: Segment dashboard
FIG. 21 Hospitals market 2016 - 2028 (USD Million)
FIG. 22 Orthopedic clinics/ambulatory surgical centers (ASCs) market 2016 - 2028 (USD Million)
FIG. 23 Regional marketplace: Key takeaways
FIG. 24 Regional movement analysis, (USD Million)
FIG. 25 North America viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 26 The U.S. viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 27 Canada viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 28 Europe viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 29 The U.K. viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 30 Germany viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 31 France viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 32 Italy viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 33 Spain viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 34 Asia Pacific viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 35 China viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 36 Japan viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 37 India viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 38 South Korea viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 39 Australia viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 40 Latin America viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 41 Brazil viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 42 Mexico viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 43 Argentina viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 44 Colombia viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 45 Middle East & Africa viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 46 South Africa viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 47 Saudi Arabia viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 48 UAE viscosupplementation market, 2016 - 2028 (USD Million)
FIG. 49 Recent development & impact analysis by key market participants
FIG. 50 Competition categorization
FIG. 51 Company market position analysis
